ATE400268T1 - Bisindolylmaleimid zur behandlung von prostatakrebs und akt-vermittelten erkrankungen - Google Patents

Bisindolylmaleimid zur behandlung von prostatakrebs und akt-vermittelten erkrankungen

Info

Publication number: ATE400268T1
Authority: AT; Austria
Prior art keywords: cancer; sup; sub; administering; patient
Prior art date: 2003-10-24

Application number

AT04793891T

Other languages

English (en)

Inventor

Jeremy Graff

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-24

Filing date

2004-10-08

Publication date

2008-07-15

2004-10-08 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2008-07-15 Application granted granted Critical

2008-07-15 Publication of ATE400268T1 publication Critical patent/ATE400268T1/de

Links

206010060862 Prostate cancer Diseases 0.000 title abstract 2
208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 2
201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
DQYBRTASHMYDJG-UHFFFAOYSA-N Bisindolylmaleimide Chemical compound C1=CC=C2C(C=3C(=O)NC(C=3C=3C4=CC=CC=C4NC=3)=O)=CNC2=C1 DQYBRTASHMYDJG-UHFFFAOYSA-N 0.000 title 2
150000001875 compounds Chemical class 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 3
206010009944 Colon cancer Diseases 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
206010033128 Ovarian cancer Diseases 0.000 abstract 1
206010061535 Ovarian neoplasm Diseases 0.000 abstract 1
206010061902 Pancreatic neoplasm Diseases 0.000 abstract 1
208000006265 Renal cell carcinoma Diseases 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
239000003098 androgen Substances 0.000 abstract 1
208000029742 colonic neoplasm Diseases 0.000 abstract 1
208000005017 glioblastoma Diseases 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
201000004228 ovarian endometrial cancer Diseases 0.000 abstract 1
201000002528 pancreatic cancer Diseases 0.000 abstract 1
208000008443 pancreatic carcinoma Diseases 0.000 abstract 1
201000005825 prostate adenocarcinoma Diseases 0.000 abstract 1
208000015347 renal cell adenocarcinoma Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

AT04793891T 2003-10-24 2004-10-08 Bisindolylmaleimid zur behandlung von prostatakrebs und akt-vermittelten erkrankungen ATE400268T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US51429103P	2003-10-24	2003-10-24

Publications (1)

Publication Number	Publication Date
ATE400268T1 true ATE400268T1 (de)	2008-07-15

Family

ID=34549326

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04793891T ATE400268T1 (de)	2003-10-24	2004-10-08	Bisindolylmaleimid zur behandlung von prostatakrebs und akt-vermittelten erkrankungen

Country Status (6)

Country	Link
US (1)	US20060281787A1 (de)
EP (1)	EP1684747B1 (de)
AT (1)	ATE400268T1 (de)
DE (1)	DE602004014965D1 (de)
ES (1)	ES2307059T3 (de)
WO (1)	WO2005041953A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070286864A1 (en) *	2006-06-09	2007-12-13	Buck Elizabeth A	Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
US8263547B2 (en) *	2008-05-28	2012-09-11	Massachusetts Institute Of Technology	DISC-1 pathway activators in the control of neurogenesis
US9265764B2 (en) *	2009-02-27	2016-02-23	Massachusetts Institute Of Technology	Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders
BR112012024585A2 (pt)	2010-03-30	2016-05-31	Novartis Ag	inibidores de pkc para o tratamento de linfomade células b tendo sinalização do receptor de células b ativas crônicas
EP3325100A4 (de)	2015-07-17	2019-02-20	Memorial Sloan-Kettering Cancer Center	Kombinationstherapie mit pdk1- und pi3k-inhibitoren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE456367T1 (de) *	1993-12-23	2010-02-15	Lilly Co Eli	Proteinkinase c inhibitoren
WO2001030331A2 (en) *	1999-10-22	2001-05-03	Eli Lilly And Company	Therapeutic compositions including protein kinase c inhibitors
AU2001271261A1 (en) *	2000-06-29	2002-01-14	Eli Lilly And Company	Therapeutic treatment of cancer with a protein kinase c inhibitor

2004
- 2004-10-08 WO PCT/US2004/030910 patent/WO2005041953A1/en not_active Ceased
- 2004-10-08 DE DE602004014965T patent/DE602004014965D1/de not_active Expired - Lifetime
- 2004-10-08 ES ES04793891T patent/ES2307059T3/es not_active Expired - Lifetime
- 2004-10-08 EP EP04793891A patent/EP1684747B1/de not_active Expired - Lifetime
- 2004-10-08 US US10/573,632 patent/US20060281787A1/en not_active Abandoned
- 2004-10-08 AT AT04793891T patent/ATE400268T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1684747B1 (de)	2008-07-09
ES2307059T3 (es)	2008-11-16
US20060281787A1 (en)	2006-12-14
DE602004014965D1 (de)	2008-08-21
EP1684747A1 (de)	2006-08-02
WO2005041953A1 (en)	2005-05-12

Similar Documents

Publication	Publication Date	Title
NO20044475L (no)	2004-11-10	2-(2,6-diklorfenyl)-diarulimidazoler
DK1353672T3 (da)	2008-01-21	Syntese af 4-amino-thalidomidenantiomerer
DE60206911D1 (de)	2005-12-01	Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
EA200600123A1 (ru)	2006-06-30	3,5-дизамещённые индазольные соединения, фармацевтические композиции и способы опосредования или ингибирования клеточной пролиферации
EA201400111A1 (ru)	2014-09-30	Ингибиторы mek и способы их применения
EA200700321A1 (ru)	2007-08-31	Пиразолзамещённые аминогетероарильные соединения в качестве ингибиторов протеинкиназы
NO20071719L (no)	2007-05-31	Pyridylinhibitorer for "hedgehog"-signalisering
NO20052578L (no)	2005-05-27	Kombinert administrering av et indolinon med et kjemoterapeutisk middel for celleproliferasjonslidelser
EA200600892A1 (ru)	2006-12-29	Новые хинолиновые производные
NO20033858D0 (no)	2003-09-01	Aryl- og heteroarylurea-CHK1-inhibitorer for anvendelse som radiosensitiviseringsmidler og chamosensitiviseringsmidler
GT199900019A (es)	2000-08-04	Formulas farmaceuticamente estables de solucion de oxaliplatino.
DE602004024880D1 (de)	2010-02-11	Azetidincarboxamid-derivate zur verwendung zur behandlung von cb1-rezeptor-vermittelten krankheiten
ATE529406T1 (de)	2011-11-15	Aryl-harnstoffe als kinase inhibitoren
ATE493418T1 (de)	2011-01-15	Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren
EA200602196A1 (ru)	2007-06-29	Производные пиразола, композиции, содержащие эти соединения, и способы применения
ATE364605T1 (de)	2007-07-15	3-aryloxy und 3-heteroaryloxy substituierte benzo(b) thiophene als therapeutische wirkstoffe mit pi3k aktivität
ATE365735T1 (de)	2007-07-15	Cycloalkylsulfanyl-substituierte benzo böthiophene als therapeutische mittel
ATE287886T1 (de)	2005-02-15	Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b) pyridinen als cyclin- abhängige kinase-hemmer
EP1453507A4 (de)	2005-06-08	Solubilisierte topoisomerase-gift-mittel
DE60328772D1 (de)	2009-09-24	Epothilonderivat zur behandlung von hepatoma und anderen krebserkrankungen
ATE400268T1 (de)	2008-07-15	Bisindolylmaleimid zur behandlung von prostatakrebs und akt-vermittelten erkrankungen
ATE419242T1 (de)	2009-01-15	Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
ATE381930T1 (de)	2008-01-15	Kombinationsmedikationen mit einem selektiven cyclooxygenase-2-inhibitor
BRPI0415355A (pt)	2006-12-12	triarilimidazóis
ATE435224T1 (de)	2009-07-15	Neue piperidinsubstituierte diaminothiazole

Legal Events

Date	Code	Title	Description
2009-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties